|
LOC100132707 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.263800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.277700E-02 |
| Normal-vs-Stage2 |
6.483800E-02 |
| Normal-vs-Stage3 |
2.41420000000048E-05 |
| Normal-vs-Stage4 |
5.68069999999921E-05 |
| Stage1-vs-Stage2 |
6.567800E-01 |
| Stage1-vs-Stage3 |
1.362740E-03 |
| Stage1-vs-Stage4 |
3.084700E-03 |
| Stage2-vs-Stage3 |
9.064000E-02 |
| Stage2-vs-Stage4 |
9.343500E-02 |
| Stage3-vs-Stage4 |
8.844800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.300900E-03 |
| Normal-vs-AfricanAmerican |
3.51840000000214E-05 |
| Normal-vs-Asian |
7.195400E-01 |
| Caucasian-vs-AfricanAmerican |
4.191600E-02 |
| Caucasian-vs-Asian |
1.137830E-01 |
| AfricanAmerican-vs-Asian |
1.955780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.224200E-03 |
| Normal-vs-Female |
1.875230E-03 |
| Male-vs-Female |
9.811600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.829600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.073600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.391400E-04 |
| Normal-vs-Age(81-100Yrs) |
6.899300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.804800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.534600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.168800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.926100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.433800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.790400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.621000E-01 |
| Normal-vs-Grade 2 |
2.767800E-02 |
| Normal-vs-Grade 3 |
2.163000E-03 |
| Normal-vs-Grade 4 |
7.87779996791471E-09 |
| Grade 1-vs-Grade 2 |
7.823700E-02 |
| Grade 1-vs-Grade 3 |
2.260300E-02 |
| Grade 1-vs-Grade 4 |
4.813800E-04 |
| Grade 2-vs-Grade 3 |
2.808600E-01 |
| Grade 2-vs-Grade 4 |
1.65112999999106E-05 |
| Grade 3-vs-Grade 4 |
2.822400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.725600E-01 |
| Normal-vs-ccB subtype |
9.80929999999658E-05 |
| ccA subtype-vs-ccB subtype |
1.836540E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.940900E-03 |
| Normal-vs-N1 |
2.943200E-03 |
| N0-vs-N1 |
1.265590E-01 |
|
|
